TABLE 3.

Results of blood tests after CAS/IMB administration or hospitalization

CAS/IMB group	Administration	3–5 days after administration	Non‐CAS/IMB group	Hospitalization	3–5 days after hospitalization
WBC (/μL)	5540 (4207–6150)	6080 (5325–8175)	WBC (/μL)	6700 (5400–7430)	4125 (3428–6063)
Hb (g/dL)	11.1 (10.7–12.4)	11.1 (10.0–12.0)	Hb (g/dL)	11.7 (10.4–12.3)	10.8 (10.0–11.9)
Plt (×10 000/μL)	18.4 (17.3–22.2)	20.8 (17.1–26.1)	Plt (×10 000/μL)	20.7 (19.2–22.7)	19.9 (16.3–21.2)
CRP (mg/L)	2.0 (0.7–3.1)	2.0 (1.1–3.7)	CRP (mg/L)	2.3 (0.7–2.6)	0.9 (0.6–5.0)
D‐dimer (μg/mL)	2.1 (1.2–3.5)	2.6 (1.5–3.3)	D‐dimer (μg/mL)	2.0 (0.8–3.1)	2.3 (1.3–4.3)

Note: The parameters did not differ significantly between the two groups. Values are listed in median and inter‐quartile ranges.

Abbreviations: CAS/IMB, casirivimab and imdevimab; CRP, C‐reactive protein; Hb, hemoglobin; Plt, platelet count; WBC, white blood cell count.